Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses

BACKGROUND: Patients with lung adenocarcinoma (LUAD) may be more predisposed to coronavirus disease 2019 (COVID-19) and have a poorer prognosis. Currently, there is still a lack of effective anti-LUAD/COVID-19 drugs. Thus, this study aimed to screen for an effective anti-LUAD/COVID-19 drug and explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kun, Wang, Ke, Zhang, Chaoguo, Teng, Xiuli, Li, Dan, Chen, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214478/
https://www.ncbi.nlm.nih.gov/pubmed/35733175
http://dx.doi.org/10.1186/s12885-022-09763-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214478/
https://www.ncbi.nlm.nih.gov/pubmed/35733175
http://dx.doi.org/10.1186/s12885-022-09763-2

Ejemplares similares